Pristine+ (Everolimus Eluting Cobalt Chromium Coronary Stent System)

Features:

Pristine+ elutes Everolimus drug which is the most preferred drug by most of the interventional cardiologists
The basic stent platform for Pristine+ is L605 Cobalt Chromium stent
The strut thickness for Pristine+ is 60 μm
Pristine+ displays minimum recoil and excellent radial strength contributed by its unique open and closed cell stent design and strut locking mechanism
Pristine+ comes with rapid exchange Delivery System which enhances its efficacy
Uniform Everolimus Coating thickness and precise in Everolimus Drug Release Kinetics as 95 +/- 5% of Everolimus is released within 120 days
Hydrophilic Coated Stent Delivery System
Designed for utmost safety – Pristine+ displays one of the lowest entry profiles
Completely biodegradable, biocompatible polymer (PLGA carrier) – Loading dose density of 1.0μg/mm²

Parameter	Specification
Available Stent Lengths	08, 10, 12, 13, 15, 16, 18, 20, 24, 28, 32, 36, 40, 42, 44 and 48mm
Available Stent Diameters	2.25, 2.50, 2.75, 3.00, 3.50, 4.00, 4.50 and 5.00mm
Stent Design	Open and Closed
Stent Platform	Co Cr (L605 Cobalt Chromium)
Stent Strut Thickness	60 μm
Stent Foreshortening	< 2%
Recoil	< 4%
Drug	Everolimus
Delivery System	Hydrophilic Coated PTCA Catheter
Polymer Type	Biodegradable PLGA Polymer
Drug Coating Thickness	3 μm